Financial Summary (All financials)
| In millions, except per share items | Mar-31-22 | Mar-31-21 | Mar-31-20 |
| Revenues | 55.3 | 23.8 | 67.7 |
| Revenue growth | 132.3% | -64.8% | |
| Cost of goods sold | 9.0 | 2.1 | 1.1 |
| Gross profit | 46.3 | 21.7 | 66.6 |
| Gross margin | 83.8% | 91.4% | 98.3% |
| Research and development | 483.0 | 236.6 | 263.2 |
| General and administrative | 775.0 | 259.9 | 335.8 |
| EBIT | -1,211.7 | -474.8 | -532.4 |
| EBIT margin | -2191.8% | -1995.2% | -786.6% |
| Pre-tax income | -923.7 | -898.5 | -561.0 |
| Income taxes | 0.4 | 1.7 | 7.1 |
| Earnings from continuing ops | -845.3 | -809.2 | -377.9 |
| Earnings from discontinued ops | | | 1,578.4 |
| Net income | -845.3 | -809.2 | 1,200.5 |
| Net margin | -1528.9% | -3400.9% | 1773.6% |
| |
| Diluted EPS | ($1.26) | ($1.28) | ($0.59) |
| Shares outstanding (diluted) | 669.8 | 630.0 | 640.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|